5-Fluoro-2-Methylbenzoic Acid CAS 33184-16-6 Assay ≥98.0% Rucaparib Intermediate

Short Description:

Chemical Name: 5-Fluoro-2-Methylbenzoic Acid 

CAS: 33184-16-6

Assay: ≥98.0%

Appearance: White or Off-White Powder

Intermediate of Rucaparib (CAS 283173-50-2) for the treatments Ovarian Cancer

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Manufacturer Supply, High Purity, Commercial Production 
Chemical Name: 5-Fluoro-2-Methylbenzoic Acid 
CAS: 33184-16-6

Chemical Properties:

Chemical Name 5-Fluoro-2-Methylbenzoic Acid
Synonyms 5-Fluoro-o-toluic Acid
CAS Number 33184-16-6
CAT Number RF-PI414
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C8H7FO2 
Molecular Weight 154.14 
Melting Point  130.0 to 132.0℃ (lit.)
Solubility Soluble in Methanol
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White or Off-White Powder
Assay ≥98.0%
Loss on Drying ≤0.50%
Residue on Ignition ≤0.20%
Total Impurities ≤2.0%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

1

FAQ:

Application:

5-Fluoro-2-Methylbenzoic Acid (CAS 33184-16-6) is used in preparation of novel iminothiazole derivatives as cannabinoid receptor ligands. 5-Fluoro-2-Methylbenzoic Acid can be used in the synthesis of Rucaparib (CAS 283173-50-2). Rucaparib is used to help maintain the response to other treatments for certain types of ovarian cancer (cancer that begins in the female reproductive organs where eggs are formed), fallopian tube (tube that transports eggs released by the ovaries to the uterus), and primary peritoneal (layer of tissue that lines the abdomen) cancer It is also used to treat certain types of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer in people with a specific gene who have not improved after treatment with at least two other therapies. Rucaparib is in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer cells. 

  • Write your message here and send it to us